Found: 280
Select item for more details and to access through your institution.
2023 Japan Society of clinical oncology clinical practice guidelines update for antiemesis.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 7, p. 873, doi. 10.1007/s10147-024-02535-x
- By:
- Publication type:
- Article
Long-term outcomes after non-curative endoscopic resection for esophageal squamous cell carcinoma followed by additional chemoradiotherapy.
- Published in:
- Diseases of the Esophagus, 2024, v. 37, n. 5, p. 1, doi. 10.1093/dote/doae004
- By:
- Publication type:
- Article
Early endpoints of a randomized phase II trial of preoperative chemotherapy with S-1/CDDP with or without trastuzumab followed by surgery for HER2-positive resectable gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1301C (Trigger Study)
- Published in:
- Gastric Cancer, 2024, v. 27, n. 3, p. 580, doi. 10.1007/s10120-024-01467-9
- By:
- Publication type:
- Article
Switching from FOLFIRI plus cetuximab to FOLFIRI plus bevacizumab based on early tumor shrinkage in RAS wild‐type metastatic colorectal cancer: A phase II trial (HYBRID).
- Published in:
- Cancer Medicine, 2024, v. 13, n. 7, p. 1, doi. 10.1002/cam4.7107
- By:
- Publication type:
- Article
CRP and soluble CTLA4 are determinants of anti-PD1 resistance in gastrointestinal cancer.
- Published in:
- American Journal of Cancer Research, 2024, v. 14, n. 3, p. 1174, doi. 10.62347/NQBL9998
- By:
- Publication type:
- Article
Short-term outcomes of preoperative chemotherapy with docetaxel, oxaliplatin, and S-1 for gastric cancer with extensive lymph node metastasis (JCOG1704).
- Published in:
- Gastric Cancer, 2024, v. 27, n. 2, p. 366, doi. 10.1007/s10120-023-01453-7
- By:
- Publication type:
- Article
Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metastatic gastric or gastroesophageal junction cancer (ANGEL study): an international, randomized, placebo-controlled, phase 3 trial.
- Published in:
- Gastric Cancer, 2024, v. 27, n. 2, p. 375, doi. 10.1007/s10120-023-01455-5
- By:
- Publication type:
- Article
A Phase II Study of FOLFIRI Plus Ziv-Aflibercept After Trifluridine/Tipiracil Plus Bevacizumab in Patients with Metastatic Colorectal Cancer: WJOG 11018G.
- Published in:
- Targeted Oncology, 2024, v. 19, n. 2, p. 181, doi. 10.1007/s11523-024-01043-2
- By:
- Publication type:
- Article
Protocol digest of a randomized controlled adaptive Phase II/III trial of neoadjuvant chemotherapy for Japanese patients with oesophagogastric junction adenocarcinoma: Japan Clinical Oncology Group Study JCOG2203 (NEO-JPEG).
- Published in:
- Japanese Journal of Clinical Oncology, 2024, v. 54, n. 2, p. 206, doi. 10.1093/jjco/hyad149
- By:
- Publication type:
- Article
5-year follow-up results of a JCOG1104 (OPAS-1) phase III non-inferiority trial to compare 4 courses and 8 courses of S-1 adjuvant chemotherapy for pathological stage II gastric cancer.
- Published in:
- Gastric Cancer, 2024, v. 27, n. 1, p. 155, doi. 10.1007/s10120-023-01447-5
- By:
- Publication type:
- Article
Clinical impact of skeletal muscle mass change during the neoadjuvant chemotherapy period in patients with gastric cancer: An ancillary study of JCOG1002.
- Published in:
- World Journal of Surgery, 2024, v. 48, n. 1, p. 163, doi. 10.1002/wjs.12041
- By:
- Publication type:
- Article
Role of reduction gastrectomy in patients with gastric cancer with a single non‐curable factor: Supplementary analysis of REGATTA trial.
- Published in:
- Annals of Gastroenterological Surgery, 2023, v. 7, n. 5, p. 741, doi. 10.1002/ags3.12674
- By:
- Publication type:
- Article
Association of probiotic use with nivolumab effectiveness against various cancers: A multicenter retrospective cohort study.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 16, p. 16876, doi. 10.1002/cam4.6313
- By:
- Publication type:
- Article
Randomised phase II trial of trifluridine/tipiracil (FTD/TPI) plus ramucirumab (RAM) versus trifluridine/tipiracil for previously treated patients with advanced gastric or esophagogastric junction adenocarcinoma (RETRIEVE study, WJOG15822G).
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11199-1
- By:
- Publication type:
- Article
Prognostic factors associated with the transition in treatment methods for brain metastases from colorectal cancer.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 8, p. 1043, doi. 10.1007/s10147-023-02352-8
- By:
- Publication type:
- Article
Perioperative TAS-118 plus oxaliplatin in patients with locally advanced gastric cancer: APOLLO-11 study.
- Published in:
- Gastric Cancer, 2023, v. 26, n. 4, p. 614, doi. 10.1007/s10120-023-01388-z
- By:
- Publication type:
- Article
Case report: Irinotecan-induced interstitial lung disease in an advanced colorectal cancer patient resurfacing decades after allogeneic bone marrow transplantation for aplastic anemia; a case report and narrative review of literature.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1215789
- By:
- Publication type:
- Article
Evaluation of clinical effects of a multidisciplinary-collaborated cancer support team for gastrointestinal cancer chemotherapy: prospective observational study protocol of M-CAST study.
- Published in:
- BMC Gastroenterology, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12876-023-02849-6
- By:
- Publication type:
- Article
Clinical factors associated with noncurative endoscopic submucosal dissection for the expanded indication of intestinal‐type early gastric cancer: Post hoc analysis of a multi‐institutional, single‐arm, confirmatory trial (JCOG0607)
- Published in:
- Digestive Endoscopy, 2023, v. 35, n. 4, p. 494, doi. 10.1111/den.14460
- By:
- Publication type:
- Article
A Phase II Trial of Trifluridine/Tipiracil in Combination with Cetuximab Rechallenge in Patients with RAS Wild-Type mCRC Refractory to Prior Anti-EGFR Antibodies: WJOG8916G Trial.
- Published in:
- Targeted Oncology, 2023, v. 18, n. 3, p. 369, doi. 10.1007/s11523-023-00963-9
- By:
- Publication type:
- Article
Progression patterns and site‐specific responses in advanced gastric cancer patients treated with nivolumab.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 8, p. 9322, doi. 10.1002/cam4.5689
- By:
- Publication type:
- Article
Late complication after gastrectomy for clinical stage I cancer: supplementary analysis of JCOG0912.
- Published in:
- Surgical Endoscopy & Other Interventional Techniques, 2023, v. 37, n. 4, p. 2958, doi. 10.1007/s00464-022-09804-8
- By:
- Publication type:
- Article
Comparison of clinicopathological and genomic profiles in anal squamous cell carcinoma between Japanese and Caucasian cohorts.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-30624-w
- By:
- Publication type:
- Article
Evaluating the efficacy of post-operative chemotherapy after curative resection of stage IV gastric cancer with synchronous oligo metastasis: a multicenter retrospective study.
- Published in:
- Gastric Cancer, 2023, v. 26, n. 2, p. 307, doi. 10.1007/s10120-023-01363-8
- By:
- Publication type:
- Article
Protocol digest of a phase III trial to evaluate the efficacy of preoperative chemotherapy with S-1 plus oxaliplatin followed by D2 gastrectomy with postoperative S-1 in locally advanced gastric cancer: Japan Clinical Oncology Group study JCOG1509 (NAGISA Trial)
- Published in:
- Japanese Journal of Clinical Oncology, 2023, v. 53, n. 2, p. 168, doi. 10.1093/jjco/hyac154
- By:
- Publication type:
- Article
Prediction of tissue-of-origin of early stage cancers using serum miRNomes.
- Published in:
- JNCI Cancer Spectrum, 2023, v. 7, n. 1, p. 1, doi. 10.1093/jncics/pkac080
- By:
- Publication type:
- Article
Usefulness of an S-1 dosage formula: an exploratory analysis of randomized clinical trial (JCOG1001).
- Published in:
- Gastric Cancer, 2022, v. 25, n. 6, p. 1073, doi. 10.1007/s10120-022-01315-8
- By:
- Publication type:
- Article
Temporal dynamics from phosphoproteomics using endoscopic biopsy specimens provides new therapeutic targets in stage IV gastric cancer.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-08430-7
- By:
- Publication type:
- Article
Targeting myeloid villains in the treatment with immune checkpoint inhibitors in gastrointestinal cancer.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1009701
- By:
- Publication type:
- Article
Altered mucosal immunity in HIV-positive colon adenoma: decreased CD4<sup>+</sup> T cell infiltration is correlated with nadir but not current CD4<sup>+</sup> T cell blood counts.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 8, p. 1321, doi. 10.1007/s10147-022-02188-8
- By:
- Publication type:
- Article
Study protocol of a single-arm phase 2 study evaluating the preventive effect of topical hydrocortisone for capecitabine-induced hand-foot syndrome in colorectal cancer patients receiving adjuvant chemotherapy with capecitabine plus oxaliplatin (T-CRACC study).
- Published in:
- 2022
- By:
- Publication type:
- journal article
Evaluation of clinical validity of an S-1 dosage formula based on renal function using data of the SPIRITS and the G-SOX trials.
- Published in:
- Gastric Cancer, 2022, v. 25, n. 4, p. 770, doi. 10.1007/s10120-022-01291-z
- By:
- Publication type:
- Article
Incidence and prognostic factors in severe drug-induced interstitial lung disease caused by antineoplastic drug therapy in the real world.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 7, p. 1737, doi. 10.1007/s00432-022-03932-3
- By:
- Publication type:
- Article
Correction to: Incidence and prognostic factors in severe drug-induced interstitial lung disease caused by antineoplastic drug therapy in the real world.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
A phase 1b study of andecaliximab in combination with S-1 plus platinum in Japanese patients with gastric adenocarcinoma.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-13801-1
- By:
- Publication type:
- Article
Influence of precedent drug on the subsequent therapy in the sequence of trifluridine/tipiracil with/out bevacizumab and regorafenib for unresectable or recurrent colorectal cancer.
- Published in:
- PLoS ONE, 2022, v. 17, n. 6, p. 1, doi. 10.1371/journal.pone.0269115
- By:
- Publication type:
- Article
Concordance of human equilibrative nucleoside transporter‐1 expressions between murine (10D7G2) and rabbit (SP120) antibodies and association with clinical outcomes of adjuvant chemotherapy for pancreatic cancer: A collaborative study from the JASPAC 01 trial
- Published in:
- Cancer Reports, 2022, v. 5, n. 5, p. 1, doi. 10.1002/cnr2.1507
- By:
- Publication type:
- Article
Surgical and perioperative treatment strategy for resectable esophagogastric junction cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2022, v. 52, n. 5, p. 417, doi. 10.1093/jjco/hyac019
- By:
- Publication type:
- Article
Topical corticosteroid therapy for facial acneiform eruption due to EGFR inhibitors in metastatic colorectal cancer patients: a randomized controlled trial comparing starting with a very strong or a weak topical corticosteroid (FAEISS study, NCCH1512, colorectal part).
- Published in:
- Supportive Care in Cancer, 2022, v. 30, n. 5, p. 4497, doi. 10.1007/s00520-022-06874-1
- By:
- Publication type:
- Article
Correction to: Indications for fertility preservation not included in the 2017 Japan Society of Clinical Oncology Guideline for Fertility Preservation in Pediatric, Adolescent, and Young Adult Patients treated with gonadal toxicity, including benign diseases
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Pretreatment risk factors for endoscopic noncurative resection of gastric cancers with undifferentiated‐type components.
- Published in:
- Journal of Gastroenterology & Hepatology, 2022, v. 37, n. 4, p. 758, doi. 10.1111/jgh.15798
- By:
- Publication type:
- Article
Temporal dynamics from phosphoproteomics using endoscopic biopsy specimens provides new therapeutic targets in stage IV gastric cancer.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-08430-7
- By:
- Publication type:
- Article
Adverse effects of cell-free and concentrated ascites reinfusion therapy for malignant ascites: a single-institute experience.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Real‐world emetic risk of chemotherapy and the corresponding antiemetic therapy in Japan: A study based on a nationwide database.
- Published in:
- Cancer Reports, 2022, v. 5, n. 3, p. 1, doi. 10.1002/cnr2.1482
- By:
- Publication type:
- Article
Indications for fertility preservation not included in the 2017 Japan Society of Clinical Oncology Guideline for Fertility Preservation in Pediatric, Adolescent, and Young Adult Patients treated with gonadal toxicity, including benign diseases.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 2, p. 301, doi. 10.1007/s10147-021-02082-9
- By:
- Publication type:
- Article
Impact of COVID-19 on gastric cancer treatment in Japanese high-volume centers: a JCOG stomach cancer study group survey.
- Published in:
- Surgery Today, 2022, v. 52, n. 2, p. 231, doi. 10.1007/s00595-021-02329-y
- By:
- Publication type:
- Article
Treatment Pattern for Advanced Gastric Cancer in Japan and Factors Associated with Sequential Treatment: A Retrospective Administrative Claims Database Study.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 1, p. 296, doi. 10.1007/s12325-021-01931-3
- By:
- Publication type:
- Article
Real-world safety and effectiveness of nivolumab in Japanese patients with unresectable advanced or recurrent gastric/gastroesophageal junction cancer that has progressed after chemotherapy: a postmarketing surveillance study.
- Published in:
- Gastric Cancer, 2022, v. 25, n. 1, p. 245, doi. 10.1007/s10120-021-01244-y
- By:
- Publication type:
- Article
Correction to: Real-world safety and effectiveness of nivolumab in Japanese patients with unresectable advanced or recurrent gastric/gastroesophageal junction cancer that has progressed after chemotherapy: a postmarketing surveillance study.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Association of renal function with the safety and efficacy of cisplatin plus S-1 therapy and docetaxel plus cisplatin plus S-1 therapy in patients with advanced gastric cancer: an exploratory analysis of JCOG1013.
- Published in:
- Japanese Journal of Clinical Oncology, 2022, v. 52, n. 1, p. 14, doi. 10.1093/jjco/hyab160
- By:
- Publication type:
- Article